[Choroidal neovascularization in central serous chorioretinopathy]

Yu N Yusef1,2, A G Kurguzova1, M V Budzinskaya1

  • 1Krasnov Research Institute of Eye Diseases, Moscow, Russia.

Vestnik Oftalmologii
|January 18, 2024
PubMed
Summary

This review covers central serous chorioretinopathy (CSC) with choroidal neovascularization (CNV). It highlights antiangiogenic therapy choices for better patient outcomes.